中国高血压患者微量白蛋白尿的检出率及影响因素

Detection rate and influencing factors of microalbuminuria in Chinese hypertensive patients

  • 摘要: 目的筛查中国高血压患者微量白蛋白尿(MAU)的检出率,分析MAU的相关影响因素。方法 2016年11月至2017年8月在全国600家医院对高血压患者181 053例进行调查,收集危险因素、疾病因素及降压药使用情况,测量血压并采用尿试纸法测定尿白蛋白与肌酐比值(UACR),依据高血压合并危险因素及动脉粥样硬化性心血管病(ASCVD)情况对患者合并MAU情况进行分组分析。结果最终共入组高血压患者136 483例。(1)伴MAU患者的血压显著高于不伴MAU患者,同时合并危险因素及ASCVD的高血压患者的血压显著高于其他高血压患者,联合用药患者的血压高于单药治疗患者的血压(均P<0.001)。(2)全部筛查患者的MAU检出率为28.2%(95%CI 28.0%~28.5%),同时合并危险因素及ASCVD的高血压患者的MAU检出率最高,达33.4%(4 966/14 885)。(3)多因素logistic回归分析显示:中低龄<45比65~85岁,OR=1.22(95%CI 1.16~1.28);45~<65岁比65~85岁,1.07(1.05~1.10)、女性比男性,1.13(1.10~1.15)、体质量指数(BMI)≥28 kg/m2比BMI<28 kg/m2,1.05(1.00~1.10)、居住在西部比东部,1.28(1.24~1.32)、居住在东北地区比东部,1.76(1.66~1.88)、合并ASCVD与危险因素比单纯高血压,1.23(1.18~1.28)、联合治疗比单药治疗,1.18(1.15~1.21)等患者特征是MAU的相关因素。结论具有危险因素及ASCVD的高血压患者,MAU检出率最高,且血压控制较差,应加强危险因素控制及血压管理。

     

    Abstract: Objective To investigate the detection rate of microalbuminuria(MAU) and the relevant influencing factors for MAU in Chinese hypertensive patients. Methods A cross-sectional survey was conducted from November 2016 to August 2017. A total of 181 053 hypertensive patients were recruited from 600 hospitals across China. A questionnaire was used to collect information including patients’ risk factors, disease conditions and the usage of anti-hypertensive drugs. Blood pressure was measured, and urine albumin to creatinine ratio(UACR) was determined by urine strip. Based on the combined risk factors of hypertension and atherosclerotic cardiovascular disease(ASCVD), the patients were divided into different groups. Results Finally, 136 483 patients with hypertension were screened.(1) The blood pressures were significantly higher in patients with MAU compared with those without MAU, in patients with risk factors and ASCVD compared with other hypertensive patients, in patients treated with combination therapy compared with those treated with single drug(all P<0.001).(2) The detection rate of MAU in all screened patients was 28.2%(95%CI 28.0%-28.5%), while in hypertensive patients with risk factors and ASCVD was the highest(33.4%, 4 966/14 885).(3) Multivariate logistic regression analysis showed that the younger patients(<45 years vs 65-85 years, OR=1.22, 95%CI 1.16-1.28, 45-<65 years vs 65-85 years, OR=1.07, 95%CI 1.05-1.10), female gender(vs male, OR=1.13, 95%CI 1.10-1.15), body mass index(BMI)≥28 kg/m~2(vs BMI<28 kg/m~2, OR=1.05, 95%CI 1.00-1.10), living in Western China(vs Eastern China, OR=1.28, 95%CI 1.24-1.32), living in Northeastern China(vs Eastern China, OR=1.76, 95%CI 1.66-1.88), hypertension combined with ASCVD and risk factors(vs simple hypertension, OR=1.23, 95%CI 1.18-1.28), and combination therapy(vs monotherapy, OR=1.18, 95%CI 1.15-1.21) were positively related with MAU. Conclusions The detection rate of MAU is the highest in hypertensive patients combined with risk factors and ASCVD, and their blood pressure control is poor. Therefore, risk factor control and blood pressure management should be strengthened.

     

/

返回文章
返回